165 related articles for article (PubMed ID: 20627557)
1. Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1.
Wei L; Gao X; Warne R; Hao X; Bussiere D; Gu XJ; Uno T; Liu Y
Bioorg Med Chem Lett; 2010 Jul; 20(13):3897-902. PubMed ID: 20627557
[TBL] [Abstract][Full Text] [Related]
2. 2-(3-Oxo-1,3-diphenylpropyl)malonic acids as potent allosteric ligands of the PIF pocket of phosphoinositide-dependent kinase-1: development and prodrug concept.
Wilhelm A; Lopez-Garcia LA; Busschots K; Fröhner W; Maurer F; Boettcher S; Zhang H; Schulze JO; Biondi RM; Engel M
J Med Chem; 2012 Nov; 55(22):9817-30. PubMed ID: 23106316
[TBL] [Abstract][Full Text] [Related]
3. 3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.
Stroba A; Schaeffer F; Hindie V; Lopez-Garcia L; Adrian I; Fröhner W; Hartmann RW; Biondi RM; Engel M
J Med Chem; 2009 Aug; 52(15):4683-93. PubMed ID: 19606904
[TBL] [Abstract][Full Text] [Related]
4. Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.
Busschots K; Lopez-Garcia LA; Lammi C; Stroba A; Zeuzem S; Piiper A; Alzari PM; Neimanis S; Arencibia JM; Engel M; Schulze JO; Biondi RM
Chem Biol; 2012 Sep; 19(9):1152-63. PubMed ID: 22999883
[TBL] [Abstract][Full Text] [Related]
5. Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity.
Islam I; Bryant J; Chou YL; Kochanny MJ; Lee W; Phillips GB; Yu H; Adler M; Whitlow M; Ho E; Lentz D; Polokoff MA; Subramanyam B; Wu JM; Zhu D; Feldman RI; Arnaiz DO
Bioorg Med Chem Lett; 2007 Jul; 17(14):3814-8. PubMed ID: 17531483
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.
Schulze JO; Saladino G; Busschots K; Neimanis S; Süß E; Odadzic D; Zeuzem S; Hindie V; Herbrand AK; Lisa MN; Alzari PM; Gervasio FL; Biondi RM
Cell Chem Biol; 2016 Oct; 23(10):1193-1205. PubMed ID: 27693059
[TBL] [Abstract][Full Text] [Related]
7. 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCζ.
Fröhner W; Lopez-Garcia LA; Neimanis S; Weber N; Navratil J; Maurer F; Stroba A; Zhang H; Biondi RM; Engel M
J Med Chem; 2011 Oct; 54(19):6714-23. PubMed ID: 21863889
[TBL] [Abstract][Full Text] [Related]
8. Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments.
Stockman BJ; Kothe M; Kohls D; Weibley L; Connolly BJ; Sheils AL; Cao Q; Cheng AC; Yang L; Kamath AV; Ding YH; Charlton ME
Chem Biol Drug Des; 2009 Feb; 73(2):179-88. PubMed ID: 19207420
[TBL] [Abstract][Full Text] [Related]
9. Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.
Rao AU; Xiao D; Huang X; Zhou W; Fossetta J; Lundell D; Tian F; Trivedi P; Aslanian R; Palani A
Bioorg Med Chem Lett; 2012 Jan; 22(2):1068-72. PubMed ID: 22182499
[TBL] [Abstract][Full Text] [Related]
10. Use of a fluorescent ATP analog to probe the allosteric conformational change in the active site of the protein kinase PDK1.
Hindie V; Lopez-Garcia LA; Biondi RM
Methods Mol Biol; 2012; 928():133-41. PubMed ID: 22956138
[TBL] [Abstract][Full Text] [Related]
11. Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.
Gracias V; Ji Z; Akritopoulou-Zanze I; Abad-Zapatero C; Huth JR; Song D; Hajduk PJ; Johnson EF; Glaser KB; Marcotte PA; Pease L; Soni NB; Stewart KD; Davidsen SK; Michaelides MR; Djuric SW
Bioorg Med Chem Lett; 2008 Apr; 18(8):2691-5. PubMed ID: 18362070
[TBL] [Abstract][Full Text] [Related]
12. Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors.
Smith L; Piatnitski EL; Kiselyov AS; Ouyang X; Chen X; Burdzovic-Wizemann S; Xu Y; Pan W; Chen X; Wang Y; Rosler RL; Patel SN; Chiang HH; Milligan DL; Columbus J; Wong WC; Doody JF; Hadari YR
Bioorg Med Chem Lett; 2006 Mar; 16(6):1643-6. PubMed ID: 16412636
[TBL] [Abstract][Full Text] [Related]
13. The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1.
Xu X; Chen Y; Fu Q; Ni D; Zhang J; Li X; Lu S
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):361-374. PubMed ID: 30734603
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and characterization of "clickable" 4-anilinoquinazoline kinase inhibitors.
Perera BG; Maly DJ
Mol Biosyst; 2008 Jun; 4(6):542-50. PubMed ID: 18493651
[TBL] [Abstract][Full Text] [Related]
15. Thieno[3,2-d]pyrimidin-4(3H)-one derivatives as PDK1 inhibitors discovered by fragment-based screening.
Lee AC; Ramanujulu PM; Poulsen A; Williams M; Blanchard S; Ma DM; Bonday Z; Goh KL; Goh KC; Goh MK; Wood J; Dymock BW
Bioorg Med Chem Lett; 2012 Jun; 22(12):4023-7. PubMed ID: 22591730
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of Rho kinase inhibitors (II).
Iwakubo M; Takami A; Okada Y; Kawata T; Tagami Y; Ohashi H; Sato M; Sugiyama T; Fukushima K; Iijima H
Bioorg Med Chem; 2007 Jan; 15(1):350-64. PubMed ID: 17046269
[TBL] [Abstract][Full Text] [Related]
17. Fused protein of deltaPKC activation loop and PDK1-interacting fragment (deltaAL-PIF) functions as a pseudosubstrate and an inhibitory molecule for PDK1 when expressed in cells.
Seki T; Irie N; Nakamura K; Sakaue H; Ogawa W; Kasuga M; Yamamoto H; Ohmori S; Saito N; Sakai N
Genes Cells; 2006 Sep; 11(9):1051-70. PubMed ID: 16923125
[TBL] [Abstract][Full Text] [Related]
18. PDK1 and PKB/Akt: ideal targets for development of new strategies to structure-based drug design.
Harris TK
IUBMB Life; 2003 Mar; 55(3):117-26. PubMed ID: 12822887
[TBL] [Abstract][Full Text] [Related]
19. Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.
Engel M; Hindie V; Lopez-Garcia LA; Stroba A; Schaeffer F; Adrian I; Imig J; Idrissova L; Nastainczyk W; Zeuzem S; Alzari PM; Hartmann RW; Piiper A; Biondi RM
EMBO J; 2006 Nov; 25(23):5469-80. PubMed ID: 17110931
[TBL] [Abstract][Full Text] [Related]
20. PIF-pocket as a target for C. albicans Pkh selective inhibitors.
Pastor-Flores D; Schulze JO; Bahí A; Giacometti R; Ferrer-Dalmau J; Passeron S; Engel M; Süss E; Casamayor A; Biondi RM
ACS Chem Biol; 2013 Oct; 8(10):2283-92. PubMed ID: 23911092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
